Nanomedicine in cancer stem cell therapy: from fringe to forefront

被引：20
|
作者：
Tabassum, Nazish [1 ]
Verma, Vinod [1 ]
Kumar, Manoj [2 ]
Kumar, Ashok [3 ]
Singh, Birbal [4 ]
机构：
[1] Univ Allahabad, Ctr Biotechnol, Nehru Sci Complex, Allahabad 211002, Uttar Pradesh, India
[2] ICMR, NIREH, Kamla Nehru Hosp Bldg, Bhopal, India
[3] MLK Post Grad Coll, Dept Zool, Balrampur, India
[4] Indian Vet Res Inst, Reg Stn, Palampur, Himachal Prades, India
来源：
CELL AND TISSUE RESEARCH | 2018年 / 374卷 / 03期
关键词：
Nanomedicine; Nanomaterials; Nanodevice; Cancer stem cells (CSCs); Drug delivery; TARGETED THERAPY; PHASE-I/II; IN-VITRO; REXIN-G; NANOPARTICLES; DRUG; COMBINATION; DELIVERY; DOXORUBICIN; PACLITAXEL;
D O I：
10.1007/s00441-018-2928-5
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Nanomedicine is the spin-off of modern medicine and nanotechnology and aims to prevent and treat diseases using nanoscale materials such as biocompatible nanoparticles and nanorobots. Targeted cellular and tissue-specific clinical applications with maximal therapeutic effects and insignificant side effects could be achieved by the pursuit of nanotechnology in medicine and healthcare regimen. The majority of conventional cancer therapies eliminate the cells of the tumor but not the cancer stem cells (CSCs). Conversely, the use of nanotechnology in CSC-based therapies is an emerging field of biomedical sciences. This article summarizes the recent trends and application of nanomedicine especially in CSC therapy along with its limitations.
引用
收藏
页码：427 / 438
页数：12
相关论文
共 50 条
  • [1] Nanomedicine in cancer stem cell therapy: from fringe to forefront
    Nazish Tabassum
    Vinod Verma
    Manoj Kumar
    Ashok Kumar
    Birbal Singh
    Cell and Tissue Research, 2018, 374 : 427 - 438
  • [2] Nanomedicine-mediated cancer stem cell therapy
    Shen, Song
    Xia, Jin-Xing
    Wang, Jun
    BIOMATERIALS, 2016, 74 : 1 - 18
  • [3] New challenges in the use of nanomedicine in cancer therapy
    Rasool, Mahmood
    Malik, Arif
    Waquar, Sulayman
    Arooj, Mahwish
    Zahid, Sara
    Asif, Muhammad
    Shaheen, Sumaira
    Hussain, Abrar
    Ullah, Hamid
    Gan, Siew Hua
    BIOENGINEERED, 2022, 13 (01) : 759 - 773
  • [4] Advantages of Nanomedicine in Cancer Therapy: A Review
    Wang, Chao
    Zhang, Shan
    ACS APPLIED NANO MATERIALS, 2023, 6 (24) : 22594 - 22610
  • [5] Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
    He, Lili
    Gu, Jian
    Lim, Lee Y.
    Yuan, Zhi-xiang
    Mo, Jingxin
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [6] Mitochondria-Targeted Nanomedicine for Enhanced Efficacy of Cancer Therapy
    Gao, Yan
    Tong, Haibei
    Li, Jialiang
    Li, Jiachen
    Huang, Di
    Shi, Jisen
    Xia, Bing
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [7] Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives
    Lin, Luobin
    He, Wanxin
    Guo, Yingxin
    Zheng, Qinzhou
    Liang, Zefeng
    Wu, Danyang
    Li, Huaqin
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [8] Cancer stem cells and drug resistance: the potential of nanomedicine
    Vinogradov, Serguei
    Wei, Xin
    NANOMEDICINE, 2012, 7 (04) : 597 - 615
  • [9] Design and application of ferritin-based nanomedicine for targeted cancer therapy
    Zhang, Baoli
    Fan, Kelong
    NANOMEDICINE, 2025, 20 (05) : 481 - 500
  • [10] Epigenetics advancing personalized nanomedicine in cancer therapy
    Liu, Shujun
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (13) : 1532 - 1543
12345